| [1] |
Cooke DT, Nguyen DV, Yang Y, et al. Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy[J]. Ann Thorac Surg，2010，90(3)：943-948.
|
| [2] |
Travis WD, Brambilla E, Burke AP, et al. WHO classification of tumours of the lung, pleura, thymus and heart[R]. Lyon：International Agency for Research on Cancer, 2015.
|
| [3] |
Maeda H, Matsumura A, Kawabata T, et al. Adenosquamous carcinoma of the lung: Surgical results as compared with squamous cell and adenocarcinoma cases[J]. Eur J Cardiothorac Surg, 2012，41(2)：357-361.
|
| [4] |
Filosso PL, Ruffini E, Asioli S, et al. Adenosquamous lung carcinomas: a histologic subtype with poor prognosis[J]. Lung Cancer, 2011，74(1)：25-29.
|
| [5] |
Gawrychowski J, Brulinski K, Malinowski E, et al. Prognosis and survival after radical resection of primary adenosquamous lung carcinoma[J]. Eur J Cardiothorac Surg, 2005，27(4)：686-692.
|
| [6] |
Bastide K, Ugolin N, Levalois C, et al. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level？[J] Lung Cancer，2010，68(1)：1-9.
|
| [7] |
Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the tnm stage groupings in the forthcoming (seventh) edition of the tnm classification of malignant tumours[J]. J Thorac Oncol, 2007，2(8)：706-714.
|
| [8] |
Watanabe Y, Tsuta K, Kusumoto M, et al. Clinicopathologic features and computed tomographic findings of 52 surgically resected adenosquamous carcinomas of the lung[J]. Ann Thorac Surg, 2014，97(1)：245-251.
|
| [9] |
Ben Y, Yu H, Wang Z, et al. Adenosquamous lung carcinoma: clinical characteristics, surgical treament and prognosis[J]. Chin Med Sci J，2000，15(4)：238-240.
|
| [10] |
Mordant P, Grand B, Cazes A, et al. Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implications[J]. Ann Thorac Surg, 2013，95(4)：1189-1195.
|
| [11] |
Wang J, Wu N, Zheng Q, et al. Evaluation of the 7th edition of the tnm classification for lung cancer at a single institution[J]. J Cancer Res Clin Oncol, 2014，140(7)：1189-1195.
|
| [12] |
Bergman P, Brodin D, Lewensohn R，et al. Validation of the 7th tnm classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases[J]. Acta Oncol，2013，52(6)：1189-1194.
|
| [13] |
Riquet M, Perrotin C, Lang-Lazdunski L, et al. Do patients with adenosquamous carcinoma of the lung need a more aggressive approach? [J]J Thorac Cardiovasc Surg，2001，122(3)：618-619.
|
| [14] |
Yung RC. Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy[J]. RespirCare Clin N Am, 2003，9(1)：51-76.
|
| [15] |
Bonifazi M, Zuccatosta L, Trisolini R, et al. Transbronchial needle aspiration: a systematic review on predictors of a successful aspirate[J]. Respiration，2013，86(2)：123-134.
|
| [16] |
Shelton DA, Rana DN, Holbrook M, et al. Adenosquamous carcinoma of the lung diagnosed by cytology：a diagnostic dilemma[J]. Diagn Cytopathol，2012，40(9)：830-833.
|
| [17] |
Dragnev KH, Gehr G, Memoli VA, et al. Alk-rearranged adenosquamous lung cancer presenting as squamous cell carcinoma: a potential challenge to histologic type triaging of nsclc biopsies for molecular studies[J]. Clin Lung Cancer, 2014，15(3)：e37-e40.
|
| [18] |
Chen J, Gao YD, Cao Y, et al. Surgical specimen histology revealed inadequacy of conventional transbronchial needle aspiration sample in the diagnosis of adenosquamous lung carcinoma[J]. J Thorac Dis, 2015，7(4)：680-686.
|
| [19] |
Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer[J]. N Engl J Med, 2006，355(24)：2542-2550.
|
| [20] |
Shiozawa T, Ishii G, Goto K, et al. Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung[J]. Pathol Int, 2013，63(2)：77-84.
|
| [21] |
Powrozek T, Krawczyk P, Ramlau R, et al. EGFR gene mutations in patients with adenosquamous lung carcinoma[J]. Asia Pac J Clin Oncol, 2014，10(4)：340-345.
|
| [22] |
Song Z, Lin B, Shao L, et al. Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma[J]. J Chin Med Assoc, 2013，76(9)：481-485.
|
| [23] |
Iwanaga K, Sueoka-Aragane N, Nakamura T, et al. The long-term survival of a patient with adenosquamous lung carcinoma harboring EGFR-activating mutations who was treated with gefitinib[J]. Intern Med, 2012，51(19)：2771-2774.
|